Detalhe da pesquisa
1.
Are High- or Low-dose SGLT2 Inhibitors Associated With Cardiovascular and Respiratory Adverse Events? A Meta-analysis.
J Cardiovasc Pharmacol
; 79(5): 655-662, 2022 05 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35058411
2.
Capn4 contributes to tumour growth and metastasis of hepatocellular carcinoma by activation of the FAK-Src signalling pathways.
J Pathol
; 234(3): 316-28, 2014 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-24962955
3.
CXCL5 contributes to tumor metastasis and recurrence of intrahepatic cholangiocarcinoma by recruiting infiltrative intratumoral neutrophils.
Carcinogenesis
; 35(3): 597-605, 2014 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-24293410
4.
Quantitative assessment of the effect of glutathione S-transferase genes GSTM1 and GSTT1 on hepatocellular carcinoma risk.
Tumour Biol
; 35(5): 4007-15, 2014 May.
Artigo
Inglês
| MEDLINE | ID: mdl-24399650
5.
Serial circulating tumor DNA profiling predicts tumor recurrence after liver transplantation for liver cancer.
Hepatol Int
; 18(1): 254-264, 2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-37980313
6.
Macro CD5L+ deteriorates CD8+T cells exhaustion and impairs combination of Gemcitabine-Oxaliplatin-Lenvatinib-anti-PD1 therapy in intrahepatic cholangiocarcinoma.
Nat Commun
; 15(1): 621, 2024 Jan 20.
Artigo
Inglês
| MEDLINE | ID: mdl-38245530
7.
Overexpression of CXCL5 mediates neutrophil infiltration and indicates poor prognosis for hepatocellular carcinoma.
Hepatology
; 56(6): 2242-54, 2012 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-22711685
8.
Loss of 5-hydroxymethylcytosine induces chemotherapy resistance in hepatocellular carcinoma via the 5-hmC/PCAF/AKT axis.
Cell Death Dis
; 14(2): 79, 2023 02 02.
Artigo
Inglês
| MEDLINE | ID: mdl-36732324
9.
Toripalimab combined with lenvatinib and GEMOX is a promising regimen as first-line treatment for advanced intrahepatic cholangiocarcinoma: a single-center, single-arm, phase 2 study.
Signal Transduct Target Ther
; 8(1): 106, 2023 03 17.
Artigo
Inglês
| MEDLINE | ID: mdl-36928584
10.
Pemigatinib in previously treated Chinese patients with locally advanced or metastatic cholangiocarcinoma carrying FGFR2 fusions or rearrangements: A phase II study.
Cancer Med
; 12(4): 4137-4146, 2023 02.
Artigo
Inglês
| MEDLINE | ID: mdl-36127767
11.
CD151 modulates expression of matrix metalloproteinase 9 and promotes neoangiogenesis and progression of hepatocellular carcinoma.
Hepatology
; 52(1): 183-96, 2010 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-20578262
12.
High expression levels of putative hepatic stem/progenitor cell biomarkers related to tumour angiogenesis and poor prognosis of hepatocellular carcinoma.
Gut
; 59(7): 953-62, 2010 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-20442200
13.
Plasma MicroRNA Panel Predicts Early Tumor Recurrence in Patients with Hepatocellular Carcinoma after Liver Transplantation.
J Cancer
; 12(23): 7190-7200, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-34729120
14.
CTLA-4 Synergizes With PD1/PD-L1 in the Inhibitory Tumor Microenvironment of Intrahepatic Cholangiocarcinoma.
Front Immunol
; 12: 705378, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-34526987
15.
Cytokeratin 10 and cytokeratin 19: predictive markers for poor prognosis in hepatocellular carcinoma patients after curative resection.
Clin Cancer Res
; 14(12): 3850-9, 2008 Jun 15.
Artigo
Inglês
| MEDLINE | ID: mdl-18559605
16.
Osteopontin combined with CD44, a novel prognostic biomarker for patients with hepatocellular carcinoma undergoing curative resection.
Oncologist
; 13(11): 1155-65, 2008 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-18997126
17.
[Analysis of the risk factors influencing the prognosis of orthotopic liver transplantation for hepatocellular carcinoma and summary of relevant clinical experience].
Zhonghua Yi Xue Za Zhi
; 86(18): 1232-5, 2006 May 16.
Artigo
Chinês
| MEDLINE | ID: mdl-16796877
18.
Liver transplantation for patients with hepatocellular carcinoma at the Liver Cancer Institute of Fudan University, China.
Chin Med J (Engl)
; 118(8): 654-9, 2005 Apr 20.
Artigo
Inglês
| MEDLINE | ID: mdl-15899120
19.
Genetic variations in plasma circulating DNA of HBV-related hepatocellular carcinoma patients predict recurrence after liver transplantation.
PLoS One
; 6(10): e26003, 2011.
Artigo
Inglês
| MEDLINE | ID: mdl-21998744
20.
Metadherin promotes hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition.
Clin Cancer Res
; 17(23): 7294-302, 2011 Dec 01.
Artigo
Inglês
| MEDLINE | ID: mdl-21976539